Return to Article Details
Chimeric ScFv Monoclonal Antibody Composed of Tocilizumab-Light Chain, Heavy Chain, and Bacterial Flagellin for the Treatment of Autoimmune Disorder: Insilco Design and Cytotoxicity Study
Download
Download PDF
This is an outdated version published on November 2, 2022. Read the
most recent version
.